TDVAX (Tetanus and diphtheria toxoid vaccine manufactured by MassBiologics.) (Discontinued by the manufacturer in 2024.)
- Frequently Reported Adverse Events: Pre-licensing clinical trial data on adverse events following TDVAX are not listed as part of the product insert.
- Serious Reported Adverse Events: After licensure (post marketing) adverse event reports have included injection site pain, swelling, warmth, itching and hypersensitivity; fever; cellulitis; nausea; rash; joint and muscle pain; dizziness; convulsion; malaise; headache.
